We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Shield Therapeutics Plc | STX | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.10 | -7.55% | 1.225 | 13:30:40 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.325 | 1.075 | 1.325 | 1.225 | 1.325 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 24/4/2024 10:34 by reviewwworld From day 1 I assigned zero value to Edison research. I mean, STX pay them to write it. It's like asking your best mate to write your school report. Mad that such a thing exists, sad that such a thing is permitted by the FCA. |
Posted at 23/4/2024 13:48 by weatherman It means STX are cutting costs to the bone. |
Posted at 05/4/2024 18:52 by bolitix Forget my last - it was just some stupid link someone gave me to an STX question but wrong company |
Posted at 22/3/2024 16:42 by weatherman Maybe STX should appoint Peony Li as their marketing head - turnover of £5m already on her business selling bladder products through Boots. |
Posted at 06/3/2024 14:56 by sam_ From another STX chat board:“ we have several major shareholders, each holding less than 5% of the company's shares. This percentage serves as the requisite threshold for UK companies to inform the market of any changes in their holdings through a TR1 notification. Jupiter Asset Management Ltd 4.364 % Premier Fund Managers Ltd. 3.836 % LGT Capital Partners AG (Investment Management) 3.669 % KW Investment Management Ltd. 2.641 % Jarvis Investment Management Ltd. 1.680 % Given the substantial number of shares traded at the end of last month, I am inclined to believe that at least two major shareholders have offloaded their shares to the market and cashed out. Regardless, the past is behind us, and we've observed a nice buying momentum gaining traction since the start of this week. I can see the share price smoothly rise back to the 4s from its current level. The technical chart is currently indicating a significant oversold condition on both the weekly and daily charts, making it an appealing prospect for chart and momentum traders as well.” |
Posted at 27/2/2024 21:17 by bolitix If that 20% assumption proved right (lets face that is half of what they achieved 2023 so why not)they would be on a US sales target of 184k YE24 and 381k YE25. Given the $145 price tag is targeted to be $220-240 by then all looks rosy. But a 208% US sales increase left us at 2.33p this morning so something not right at STX |
Posted at 27/2/2024 15:05 by bolitix I said a couple of months ago this CEO will take this below 1p share price Even with a 200% sales gain over 2023 he has managed to take the share price down 25 fold to date. VTRS share price is about 13p and i dont know AOPs but which of these who take over we cant expect the share price to ever top theirs. Now i am not gloating here as i have lost lots on STX! |
Posted at 23/2/2024 18:20 by weatherman STX has been manipulated down, some people have made a lot of money by taking advantage of debt weakness - while trusting shareholders have been shafted. STX would have been better off being a private company. Still some of the trouble has been self inflicted - the latest debacle of reporting wrong data, and a slower Q4 with missed targets. Even so, the revenue shortfall wasn't that much with a higher unit price being achieved above forecasts. |
Posted at 21/2/2024 17:55 by purchaseatthetop bolitix - 11 Jul 2023 - 14:26:51 - 11250 of 13533 Shield Therapeutics: poised for a US licensing deal - STXSo hold another 6 months. If STX gets anywhere near the CFO's YE2023 Forecast of 147K sales this will fly Hmmmnnn.errrrrr̷ |
Posted at 05/10/2023 14:26 by reviewwworld And oil floats on water. I mean what's the correlation smh. This isn't anything like Tesla. STX is not best in class. STX has not got a monstrous public profile, tech-lime valuations and a gold star CEO. STX is not addressing a market anywhere near in size to the company that becomes to electric cars what Ford was before it. STX has a very limited life and no other product touching the sides. Yes investors look outward to future years but they also have to report annualised returns to shareholders. My point is why would you hold it NOW. Realistically what is going to happen in the next 12 months?Sure growth COULD continue at the rapid rate we have seen. What's to stop the company saying "oh this is great, but if we had even MORE money from investors imagine how good the growth would look then!!! Which is essentially the story of the past 2 years... On repeat. You're betting a broken clock isn't right twice a day... |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
